Clinical Trial Update: First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of ISH0613 to assess safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects and individuals with systemic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• ISH0613

Snippet

Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. | Conditions: Healthy Subjects (HS), SLE (Systemic Lupus) | Phase 1 | Status: NOT_YET_RECRUITING